New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 9, 2014
10:55 EDTDYN, SLXP, VIP, NKTR, BDSI, CCIH, BNNY, USG, IDIX, ACHNHigh option volume stocks:
High option volume stocks: BNNY VIP ACHN CCIH SLXP IDIX BDSI DYN USG NKTR
News For BNNY;VIP;ACHN;CCIH;SLXP;IDIX;BDSI;DYN;USG;NKTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 23, 2015
10:15 EDTACHNOptions with decreasing implied volatility
Subscribe for More Information
January 22, 2015
10:35 EDTACHNOptions with decreasing implied volatility
Options with decreasing implied volatility: CZR ACHN NFLX SN NBR TLM CREE BBY LNCO BBRY
January 21, 2015
12:30 EDTSLXPGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
January 20, 2015
14:31 EDTSLXPSalix climbs after Reuters says strategic options being explored
Shares of Salix Pharmaceuticals (SLXP) are jumping after Reuters reported that the company is working with investment bank Centerview Partners to explore strategic options, including a possible sale to a larger peer. On January 6, Cantor and Piper Jaffray wrote that the retirement of the company's CEO increased the chances that it would look to sell itself. Salix develops treatments for bowel disorders. WHAT'S NEW: Salix has hired Centerview Partners to help it explore various options, including a possible sale to a larger drug maker, Reuters reported this afternoon, citing three unnamed sources. However, Salix has not determined if it will look to sell itself now or wait until it hires a new CEO, the news service added. ANALYST VIEW: On January 6, after Salix announced that its CEO would retire, Cantor analyst Irina Koffler wrote that the retirement could "pave the way" for a sale of the company. The analyst wrote that "all options could be on the table." She raised her price target on the stock to $145 from $127 and kept a Buy rating on Salix shares. Similarly, Piper Jaffray analyst David Amsellem wrote that the CEO's departure, combined with the company's announcement last month of an accelerated workdown of its inventory levels, sets the stage for an eventual sale of the company. There would be "ample interest" in acquiring the company, added the analyst, who kept a $130 price target and Overweight rating on the shares. PRICE ACTION: In mid-afternoon trading, Salix jumped about 5% to trade near $126 per share.
14:23 EDTSLXPSalix calls active on exploring options report
Subscribe for More Information
14:13 EDTSLXPSalix exploring options, including potential sale, Reuters reports
Subscribe for More Information
13:48 EDTSLXPSalix exploring options with help of Centerview, Reuters reports
January 19, 2015
13:15 EDTVIPVimpelCom COO Rene Schuster leaving company
Subscribe for More Information
10:59 EDTDYNFERC requests additional information to process Dynegy acquisitions applications
Dynegy (DYN) announced that the Federal Energy Regulatory Commission, FERC, issued a letter requesting additional information to process the applications filed with FERC on September 11 for approval of Dynegy’s acquisition of Duke Energy Midwest Generation (DUK) assets and retail business and EquiPower Resources and Brayton Point Holdings assets. The company plans to respond fully within the 30-day period however, due to this request for additional information, we do not expect the transactions to close by the end of the first quarter 2015. Dynegy, Duke and Energy Capital Partners remain committed to closing the transactions as quickly as possible. The only regulatory approval remaining is from FERC.
January 15, 2015
07:59 EDTUSGUSG consensus estimates have upside, says Jefferies
Subscribe for More Information
January 13, 2015
13:23 EDTNKTRNektar says year ending cash, investments totaled $262.8M
Subscribe for More Information
10:00 EDTDYNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Midstream Partners (AMID) initiated with a Buy at Wunderlich... Ameriprise (AMP) initiated with a Buy at Deutsche Bank... Applied DNA Sciences (APDN) initiated with a Buy at Maxim... Axalta Coating (AXTA) initiated with an Outperform at RW Baird... Bellicum Pharmaceuticals (BLCM) initiated with a Buy at Citigroup... Bonanza Creek (BCEI) initiated with a Hold at Deutsche Bank... ConocoPhillips (COP) initiated with an Underweight at JPMorgan... Core-Mark (CORE) initiated with a Buy at Jefferies... Dick's Sporting (DKS) initiated with an In-Line at Imperial Capital... Dynegy (DYN) reinstated with an Overweight at Barclays... Gannett (GCI) initiated with an Outperform at Wells Fargo... Gran Tierra (GTE) initiated with an Outperformer at CIBC... HomeAway (AWAY) initiated with an Outperform at RBC Capital... Juno Therapeutics (JUNO) initiated with a Neutral at Goldman... MakeMyTrip (MMYT) initiated with a Buy at BofA/Merrill... PDC Energy (PDCE) initiated with a Hold at Deutsche Bank... PNC Financial (PNC) initiated with a Hold at Evercore ISI... Proofpoint (PFPT) initiated with a Buy at Summit Research... Sensata (ST) initiated with a Buy at Stifel... Southcross Energy Partners (SXE) initiated with a Buy at Wunderlich... Suncor (SU) initiated with an Overweight at JPMorgan... U.S. Bancorp (USB) initiated with a Hold at Evercore ISI... United Financial (UBNK) initiated with a Sector Perform at RBC Capital... Vantiv (VNTV) initiated with an Outperform at Keefe Bruyette... Wells Fargo (WFC) initiated with a Hold at Evercore ISI.
06:10 EDTACHNAchillion implied volatility of 98 at lower end of index mean range
Subscribe for More Information
05:34 EDTDYNDynegy reinstated with an Overweight at Barclays
Subscribe for More Information
January 12, 2015
09:31 EDTDYNDynegy upgraded to Buy from Hold at Tudor Pickering
Subscribe for More Information
07:19 EDTCCIHUBS to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use